SARS-CoV-2 co-detection with influenza and human respiratory syncytial virus in Ethiopia: Findings from the severe acute respiratory illness (SARI) and influenza-like illness (ILI) sentinel surveillance, January 01, 2021, to June 30, 2022
-
Published:2024-04-18
Issue:4
Volume:4
Page:e0003093
-
ISSN:2767-3375
-
Container-title:PLOS Global Public Health
-
language:en
-
Short-container-title:PLOS Glob Public Health
Author:
Shure Wolde, Tayachew AdamuORCID, Berkessa TsegayeORCID, Teka Gizaw, Biru Mengistu, Gebeyehu Ayele, Woldeab Adane, Tadesse Musse, Gonta Melaku, Agune Admikew, Hailemariam AsterORCID, Haile Bizuwork, Addis BezaORCID, Moges MulukenORCID, Lisanwork Leuel, Gizachew Lehageru, Tigabu EyasuORCID, Mekuria Zelalem, Yimer Getnet, Dereje Nebiyu, Aliy JemalORCID, Lulseged SileshiORCID, Melaku Zenebe, Abate Ebba, Gebreyes Wondwossen, Wossen Mesfin, Abayneh Aschalew
Abstract
SARS-CoV-2 co-infection with the influenza virus or human respiratory syncytial virus (RSV) may complicate its progress and clinical outcomes. However, data on the co-detection of SARS-CoV-2 with other respiratory viruses are limited in Ethiopia and other parts of Africa to inform evidence-based response and decision-making. We analyzed 4,989 patients’ data captured from the national severe acute respiratory illness (SARI) and influenza-like illness (ILI) sentinel surveillance sites over 18 months period from January 01, 2021, to June 30, 2022. Laboratory specimens were collected from the patients and tested for viral respiratory pathogens by real-time, reverse transcription polymerase chain reaction (RT-PCR) at the national influenza center. The median age of the patients was 14 years (IQR: 1–35 years), with a slight preponderance of them being at the age of 15 to less than 50 years. SARS-CoV-2 was detected among 459 (9.2%, 95% CI: 8.4–10.0) patients, and 64 (1.3%, 95% CI: 1.0–1.6) of SARS-CoV-2 were co-detected either with Influenza virus (54.7%) or RSV (32.8%) and 12.5% were detected with both of the viruses. A substantial proportion (54.7%) of SARS-CoV-2 co-detection with other respiratory viruses was identified among patients in the age group from 15 to less than 50 years. The multivariable analysis found that the odds of SARS-CoV-2 co-detection was higher among individuals with the age category of 20 to 39 years as compared to those less than 20 years old (AOR: 1.98, 95%CI:1.15–3.42) while the odds of SARS-CoV-2 co-detection was lower among cases from other regions of the country as compared to those from Addis Ababa (AOR:0.16 95%CI:0.07–0.34). Although the SARS-CoV-2 co-detection with other respiratory viral pathogens was minimal, the findings of this study underscore that it is critical to continuously monitor the co-infections to reduce transmission and improve patient outcomes, particularly among the youth and patients with ILI.
Publisher
Public Library of Science (PLoS)
Reference36 articles.
1. Prevalence of human respiratory syncytial virus, parainfluenza and adenoviruses in East Africa Community partner states of Kenya, Tanzania, and Uganda: A systematic review and meta-analysis (2007–2020).;T Umuhoza;PLoS One.,2021 2. The Burden of Respiratory Viruses and Their Prevalence in Different Geographical Regions of India: 1970–2020.;R Waghmode;Front Microbiol.,2021 3. SARS-CoV-2 and Influenza Virus Co-Infection Cases Identified through ILI/SARI Sentinel Surveillance: A Pan-India Report;N Aggarwal;The Lancet,2022 4. Molecular Evidence of Coinfection with Acute Respiratory Viruses and High Prevalence of SARS-CoV-2 among Patients Presenting Flu-Like Illness in Bukavu City, Democratic Republic of Congo.;PB Ntagereka;Canadian Journal of Infectious Diseases and Medical Microbiology,2022 5. Co-infection of SARS-CoV-2 with other respiratory viruses and performance of lower respiratory tract samples for the diagnosis of COVID-19;S Burrel;International Journal of Infectious Diseases,2021
|
|